Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BLDR✓SelectedUSD · BLDRGSK vs BLDR performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs BLDR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
BLDR return
-58.6%
Excess return
+111.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioBLDRExcessAlpha
1D-0.1%-0.8%+0.7%0.0%
7D-5.3%-9.3%+4.0%-4.4%
30D-3.7%+2.8%-6.5%-4.0%
3M-7.3%-21.7%+14.5%-5.2%
6M-4.2%-22.7%+18.5%-2.4%
YTD+0.9%-46.5%+47.4%+5.9%
1Y+7.3%-42.0%+49.3%+11.9%
3Y+52.7%-59.0%+111.8%+61.5%
All+52.7%-58.6%+111.3%+61.5%

Cumulative growth

Daily Returns

Daily percentage return beside BLDR.

Daily Out/Under-Performance

Portfolio return minus BLDR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BLDR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded BLDR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling